
About this episode
TWiV reviews the latest data on the UK variant of SARS-CoV-2, including some properties of the variant and why it is being closely studied, development of liver cancer in a participant in a adenovirus-associated virus gene therapy trial, and answers to listener questions.
Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- BSL-3 Assistant Manager position 3:39
- NERVTAG meeting minutes (pdf)
- NERVTAG
- Preliminary genomic characterization of UK variant (virological.org)
- PHE investigation of UK variant (pdf)
- N501Y does not affect antibody neutralization (Science, eLife)
- WHO notice on UK variant (WHO)
- Liver tumor during AAV gene therapy (Science)
- Letters read on TWiV 697
- Timestamps by Jolene. Thanks!
Weekly Picks
Brianne – EM Rap Podcast COVID update
Kathy – Conjunction of Jupiter and Saturn and Tony Fauci vaccinated Santa Claus
Rich – Chicken LIttle (wiki)
Vincent – virological.org
Listener Pick
Greg – Someone who wants to make a difference
Uli – XKCD on statistics
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology

TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology

TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology

TWiV 1307: My heart breaks for flu
This Week in Virology

TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology